Navigation Links
Heska Announces Financial Results for the Second Quarter of Fiscal 2013
Date:8/7/2013

LOVELAND, Colo., Aug. 7, 2013 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA; "Heska" or the "Company"), a provider of advanced veterinary diagnostic and other specialty veterinary products, today reported financial results for its second quarter ended June 30, 2013. The Company previously announced the acquisition of 54.6% of Cuattro Vet US, LLC ("Cuattro Vet USA"), which was subsequently renamed Heska Imaging US, LLC, and this acquisition is reflected in Heska's consolidated financial results for the second quarter of 2013 with no contribution in the second quarter last year.

Second Quarter 2013 Highlights:

  • Consolidated revenue for the second quarter of 2013 was essentially unchanged from the second quarter of 2012 at $18.3 million.
  • Core Companion Animal Health revenue increased approximately 1%, while Other Vaccines, Pharmaceuticals and Products revenue decreased 6.2% as compared to the second quarter of 2012.
  • Heska recognized a reserve of $1.1 million, including $768 thousand recognized in cost of revenue, related to the discontinuation of sales and long-term support for its VitalPath blood gas and electrolyte instrument.
  • Heska recognized a reserve of $453 thousand in cost of revenue related to the discontinuation of support for its legacy SpotChem chemistry instrument.
  • Gross profit was $5.0 million, inclusive of the $1.6 million in reserves described above. Gross profit decreased 37.6% year-over-year and gross margin was 27.5% compared to 44.0% in the second quarter of 2012.
  • The Company reported an operating loss of $3.6 million, inclusive of the $1.6 million in reserves described above and approximately $300 thousand in severance related expenses, compared to operating income of $383 thousand in the second quarter of 2012.
    '/>"/>

  • SOURCE Heska Corporation
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Heska Announces Quarterly Dividend of $0.10 Per Share
    2. Heska to Present at B. Riley Investor Conference
    3. Heska Corporation Announces Amendment To Its Odd-Lot Tender Offer
    4. Webcast Alert: Heska Announces Third Quarter 2012 Earnings Conference Call Webcast
    5. Heska Enters Distribution Agreement with MWI Veterinary Supply
    6. Heska Reports Third Quarter 2012 Earnings
    7. Webcast Alert: Heska Announces Fourth Quarter and Year-End 2012 Earnings Conference Call Webcast
    8. Heska Announces 19.0% Revenue Growth for Fourth Quarter of Fiscal 2012
    9. Webcast Alert: Heska Corporations Annual Meeting of Stockholders Webcast
    10. Heska Corporation to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
    11. Heska Corporation to Present at the 14th Annual B. Riley & Co. Investor Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/30/2015)... June 30, 2015  Today, the National Mobility Equipment ... 2015 National Mobility Awareness Month Local Heroes Contest on ... online entries that received 1.3 million votes. The sponsors ... Toyota Mobility , and Valley Honda Dealers ... and Vantage Mobility International (VMI) and ...
    (Date:6/30/2015)... Calif. , June 30, 2015  Avanir ... PRISM II study showing that treatment with NUEDEXTA ... reduction in symptoms of pseudobulbar affect (PBA) in ... PBA is a distressing condition characterized by sudden ... from certain neurologic diseases or brain injury. PRISM ...
    (Date:6/30/2015)... Minn. , June 30, 2015  EnteroMedics Inc. ... devices that use neuroblocking technology to treat obesity, metabolic ... its previously announced public offering  of 40,229,886 units. Each ... of a Series A warrant to purchase one share ... warrant to purchase one share of common stock, at ...
    Breaking Medicine Technology:NMEDA Announces National Contest Winners 2NMEDA Announces National Contest Winners 3Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 2Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 3Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 4Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 5Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 6Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 7EnteroMedics Inc. Announces Pricing of $35.0 Million Public Offering of Common Stock and Warrants 2EnteroMedics Inc. Announces Pricing of $35.0 Million Public Offering of Common Stock and Warrants 3
    (Date:6/30/2015)... , ... June 30, 2015 , ... ... litigation may be expedited through the use of new forms, according to attorneys ... the Joint Complaint and the Short Form Complaint, “provide guidance” for plaintiffs’ attorneys ...
    (Date:6/30/2015)... ... June 30, 2015 , ... AvePoint, the established leader in ... new apps – AvePoint Watermark, AvePoint MyWorld, and AvePoint ... apps, workers can better streamline everyday business operations and take advantage of the latest ...
    (Date:6/30/2015)... ... June 30, 2015 , ... The ... October 28-31, 2015 at Disney’s Coronado Springs Resort in Lake Buena Vista, Florida, ... Each year, this premiere event for psychiatric-mental health nursing draws more than 1,500 ...
    (Date:6/30/2015)... Texas (PRWEB) , ... June 30, 2015 , ... This ... closely aligned with the Peacock Alley story including hard work, tenacity, perseverance, commitment to ... America was born. , Born of Mary Ella Gabler's simple love of quilts, ...
    (Date:6/29/2015)... , ... June 30, 2015 , ... Sublime Beauty NATURALS® ... Off offer. The oil, ideal for natural skincare and even culinary uses, was ... way is something most people desire, and Oil Pulling can accomplish this. Oil Pulling ...
    Breaking Medicine News(10 mins):Health News:Xarelto Lawsuit News: New Xarelto Lawsuit Filings to Be Expedited 2Health News:Xarelto Lawsuit News: New Xarelto Lawsuit Filings to Be Expedited 3Health News:AvePoint Enhances Workforce Productivity and Document Protection on Microsoft Office 365 with the Release of Three New Apps 2Health News:AvePoint Enhances Workforce Productivity and Document Protection on Microsoft Office 365 with the Release of Three New Apps 3Health News:AvePoint Enhances Workforce Productivity and Document Protection on Microsoft Office 365 with the Release of Three New Apps 4Health News:American Psychiatric Nurses Association 29th Annual Conference: Continuing Education and Collaboration in Psychiatric-Mental Health and Nursing 2Health News:American Psychiatric Nurses Association 29th Annual Conference: Continuing Education and Collaboration in Psychiatric-Mental Health and Nursing 3Health News:Luxury Linen Purveyor Peacock Alley Celebrates the Fourth of July 2Health News:New Product: Transform Wellness and Oral Health With This Ancient Ayurvedic Secret and Organic Product from Sublime Beauty NATURALS® 2
    ... Studies have been conducted to see whether antihypertensive ... inhibitors // are superior to older treatments with ... the calcium channel blocker amlodipine with or without ... with or without the diuretic bendroflumethiazide. ,The ...
    ... people suffering from the bone-thinning disease osteoporosis may also ... a condition in which people have a difficult time ... markedly improve bone mineral density, or BMD, among patients ... to have thinning bones, but little study exists to ...
    ... Journal of Dental Research, caries in primary teeth may cause ... can have caries for a wide variety of reasons such ... exposure to water fluoridation, disturbance to primary teeth, and early ... caries in primary teeth have long-term effect on the oral ...
    ... products provide the necessary dietary calcium required for bone ... available that relates to growth of bones in children ... or no relationship between the two., ,Children are ... calcium for their bone development. Taking dairy products in ...
    ... In a recent study of 125,000 people it was found ... diabetes risk by half // over 12 to 18 years, ... lowered risk. ,Researchers say their study revealed an ... consumption and type-II (diabetes) independent of other risk factors. However ...
    ... cancer occur and it is the most common cancer in ... of the cases can be cured, especially if it is ... the cancer before it starts to spread. Researchers now say ... before it spreads. ,Researchers say they have found a ...
    Cached Medicine News: